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Abstract. It has been shown that the sesquiterpene lactone 
parthenolide lowers the viability of MDA-MB-231 breast 
cancer cells, in correlation with oxidative stress. The present 
report examined the different radical species produced during 
parthenolide treatment and their possible role in the toxicity 
caused by the drug. Time course experiments showed that in 
the first phase of treatment (0-8 h), and in particular in the first 
3 h, parthenolide induced dichlorofluorescein (DCF) signal 
in a large percentage of cells, while dihydroethidium (DHE) 
signal was not stimulated. Since the effect on DCF signal 
was suppressed by apocynin and diphenyleneiodonium (DPI), 
two inhibitors of NADPH oxidase (NOX), we suggest that 
parthenolide rapidly stimulated NOX activity with production 
of superoxide anion (O2
•-), which was converted by superoxide 
dismutase 1 (SOD1) into hydrogen peroxide (H2O2). In the 
second phase of treatment (8-16 h), parthenolide increased 
the number of positive cells to DHE signal. Since this event 
was not prevented by apocynin and DPI and was associated 
with positivity of cells to MitoSox Red, a fluorochrome used 
to detect mitochondrial production of O2•-, we suggest that 
parthenolide induced production of O2•- at the mitochondrial 
level independently by NOX activity in the second phase of 
treatment. Finally, in this phase, most cells became positive to 
hydroxyphenyl fluorescein (HPF) signal, a fluorescent probe to 
detect highly reactive oxygen species (hROS), such as hydroxyl 
radical and peroxynitrite. Therefore, parthenolide between 
8-16 h of treatment induced generation of O2
•- and hROS, in 
close correlation with a marked reduction in cell viability.
Introduction
Reactive oxygen species (ROS) are produced in the cells 
during aerobic metabolism. At first, molecular oxygen can 
be reduced to form superoxide anion (O2
•-) by the activity of 
NADPH oxidase (NOX) (1,2), a multicomponent enzyme, or 
by xanthine oxidase, lipoxygenase and mitochondrial oxidases 
(2). Subsequently, superoxide, a highly ROS (hROS), is 
converted by superoxide dismutase (SOD) (3,4) to hydrogen 
peroxide (H2O2), a more stable species, which can be reduced 
to water either by catalase or by glutathione peroxidase (2).
An excess of ROS (O2
•- and H2O2) is commonly referred 
to as oxidative stress. This condition, which is responsible for 
cell damage, can be induced by many diseases and a number 
of toxic agents (5).
Also, nitric oxide (NO) is implicated in pathological mech-
anisms. One of these mechanisms involves NO in a reaction 
with superoxide to form peroxynitrite (6) that is a potent 
oxidant. Peroxynitrite leads to lipid peroxidation and nitration 
of tyrosine residues in proteins with their inactivation (7).
Parthenolide, a sesquiterpene lactone found in Tanacetum 
parthenium, known for its anti-inflammatory activity, is 
currently considered an effective antitumour agent (8,9). It has 
been shown that this drug exerts its effect by inducing genera-
tion of ROS (10) and inhibiting the nuclear factor κB (NF-κB) 
(11).
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We have previously shown that parthenolide rapidly stimu-
lates ROS generation in human osteosarcoma MG-63 and 
melanoma SK-MEL-28 cells (12) as well as in breast cancer 
MDA-MB-231 cells (13). Furthermore, it has been reported 
that parthenolide induces the activity of NOX in prostate 
cancer PC3 cells (14). Recently, we demonstrated that the drug 
stimulates NOX activity with O2•- production in MDA-MB-231 
cells as well (13,15), which could be responsible for the toxic 
effects caused by the drug. These effects consist in the deple-
tion of thiol groups and glutathione, NF-κB inhibition, c-Jun 
N-terminal kinase (JNK) activation, dissipation of mitochon-
drial membrane potential (∆ψm) and necrotic effects (12,13).
The aim of the present report was to study the production 
of different oxygen species induced by parthenolide, such 
as H2O2, O2•-, and peroxynitrite, in order to demonstrate the 
relationships between these compounds and the role exerted 
by parthenolide in the induction of toxicity in MDA-MB-231 
cells.
Materials and methods
Chemicals and reagents. Parthenolide was supplied by Sigma-
Aldrich (Milan, Italy). Stock solution of parthenolide was 
prepared in dimethyl sulfoxide (DMSO) and diluted to a final 
concentration in the culture medium. Final concentration of 
DMSO employed as vehicle never exceeded 0.04% and had 
no discernible effects on MDA-MB-231 cells in comparison 
with the control. Unless otherwise indicated, all reagents were 
purchased from Sigma-Aldrich.
Cell cultures. Human breast carcinoma MDA-MB-231 cells 
were provided by Istituto Scientifico Tumori (Genoa, Italy). 
The cell line was grown as monolayer in Dulbecco's modified 
Eagle's medium (DMEM) supplemented with 10% (v/v) heat 
inactivated fetal calf serum (FCS), 2 mM glutamine and 1% 
non-essential amino acids, at 37˚C in a humidified atmosphere 
containing 5% CO2. After plating on 96- or 6-well plates, cells 
were allowed to adhere overnight and were then treated with 
chemicals or vehicle only.
Analysis of cell viability and cell necrosis. For these studies, 
the cells (8x103) were seeded into 96-well plates. Twenty-four 
hours after seeding, cells were treated with drugs for the time 
indicated in the Results. Cell viability was determined by the 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) colorimetric assay as previously reported (16). MTT is 
reduced to purple formazan in the mitochondria of living cells. 
The absorbance of the formazan was measured at 570 nm, with 
630 nm as a reference wavelength using an automatic ELISA 
plate reader (Opsys MR; Dynex Technologies, Chantilly, 
VA, USA). After treatment with the drugs, cell survival was 
estimated as a percentage of the value of the vehicle-treated 
control.
To determine membrane damage, the cells were stained 
with propidium iodide (PI), as previously reported (13). 
In particular, cells (8x103/well) were incubated in culture 
medium and treated for various times with parthenolide, 
and PI (2.0 µg/ml medium) was then added and the incuba-
tion was protracted for an additional 15 min. At the end, cell 
morphology was visualized by a Leica DMR microscope 
equipped with a DC300F camera (Leica Microsystems, 
Wetzlar, Germany) using an appropriate filter to examine PI 
(rhodamine filter with excitation wavelength of 596 nm and 
emission wavelength of 620 nm). All the images were acquired 
by Leica Q-Fluoro Software. Cells with red fluorescence were 
counted and normalized to the total number of cells/field to 
calculate the percentage of PI-positive cells. Five fields/condi-
tion were analysed.
Flow cytometric analysis. MDA-MB-231 cells (105/well) were 
incubated with parthenolide and other effectors for various 
times. At the end, the cells were trypsinized, collected, washed 
with PBS and incubated with fluorescent probes.
DCFH-DA analysis. Generation of intracellular radicals 
was measured using 5-(and-6)-carboxy-2',7'-dichlorodihy-
drofluorescein diacetate (DCFH-DA; Molecular Probe, Life 
Technologies, Eugene, OR, USA), a f luorochrome that 
passively diffuses into the cells. After cleavage of acetate 
groups by intracellular esterases, a fluorescent adduct (DCF) is 
produced by oxidation. To analyse DCF signal, the cells were 
incubated with 50 µM DCFH-DA in Hank's balanced salt solu-
tion (HBSS) for 30 min at 37˚C in darkness.
DHE analysis. O2•- production was assessed by dihydro-
ethidium (DHE) staining. The fluorochrome DHE is oxidized 
by superoxide to fluorescent ethidium that intercalates with 
nuclear DNA, staining the nucleus with a bright red fluo-
rescence. After treatment with parthenolide, the cells were 
incubated with 20 µM DHE in PBS for 15 min at 37˚C in 
darkness.
MitoSox Red analysis. To detect mitochondrial production of 
O2•-, MitoSox Red fluorochrome was used (Molecular Probe, 
Life Technologies). MitoSox Red is a mitochondria-targeted 
form of DHE that is relatively specific for O2
•- and undergoes 
oxidation to form a DNA-binding red fluorescent product (17). 
After treatment, the cells were incubated with 5 µM MitoSox 
Red in HBSS buffer for 10 min at 37˚C in the dark.
HPF analysis. Hydroxyphenyl fluorescein (HPF; Enzo Life 
Sciences Inc., Farmingdale, NY, USA) was employed to detect 
hROS). HPF is a cell permeable minimally fluorescent dye, 
which reacts with hROS (·OH, ONOO- and -OCl) and is 
converted to fluorescein, which exhibits strong, dose-depen-
dent fluorescence (18). In this case, the cells after the treatment 
were incubated with 10 µM HPF in HBSS for 1 h at 37˚C in 
the dark. Then, cells were collected and resuspended in 500 µl 
HBSS.
All analyses were performed using a Beckman Coulter 
Epics XL flow cytometer (Beckman Coulter, Brea, CA, USA) 
with appropriate filters. For DCF and HPF signals, FITC filter 
was used with excitation wavelength of 480 nm and emission 
wavelength of 525 nm. For DHE and MitoSox Red, rhodamine 
filter was used with excitation wavelength of 518 nm and 
emission wavelength of 605 nm. All the acquired data were 
analysed by EXPO32 software.
Western blot analysis. For these studies, after treatment, cells 
were washed in PBS, lysed for 30 min at 4˚C in ice-cold lysis 
ONCOLOGY REPORTS  32:  167-172,  2014 169
buffer (1% NP-40, 0.1% SDS and 0.5% sodium deoxycholate 
in PBS), containing protease inhibitor cocktail and sonicated 
three times for 10 sec. Then, protein concentration was deter-
mined by Lowry assay (19). Equal amounts of protein samples 
(50 µg/lane) were subjected to SDS-polyacrylamide gel elec-
trophoresis, then blotted to a nitrocellulose membrane.
All western blot analyses were performed using specific 
antibodies obtained from Santa Cruz Biotechnology (Santa 
Cruz, CA, USA). Detection was developed using secondary 
antibodies conjugated with alkaline phosphatase.
Protein bands were visualized using 5-bromo-4-chloro-
3-indolyl phosphate and nitro blue tetrazolium (Promega 
Italia, Milan, Italy) and their intensity was quantified by 
densitometric analysis using SMX Image software (Bio-Rad 
Laboratories Srl, Segrate, Italy).
Statistical analysis. Results are presented as means ± standard 
error. Data were analysed using the Student's t-test.
Results
Effects induced by parthenolide on the ROS. In order to estab-
lish the effect exerted by parthenolide on the generation of 
radical species, we analysed the changes induced by partheno-
lide treatment on four different fluorescent signals, DCF, DHE, 
MitoSox Red and HPF (Fig. 1).
DCFH-DA was used as a fluorescent probe for ROS. 
Although this probe is widely used for H2O2, it lacks specificity 
among ROS and reacts strongly with hROS, such as hydroxyl 
radicals and peroxynitrite (18).
The time course of the parthenolide effect exerted on DCF 
signal is reported in Fig. 1A. It was observed that in the first 
hours of treatment (1-3 h) with 25 µM parthenolide most cells 
(>90%) were positive to DCF signal. After 3 h, this percentage 
declined progressively with the time of treatment so that at 8 h 
only 40% of cells were positive to DCF. After 8 h, DCF signal 
increased again until 16 h of treatment, when DCF-positive 
cells reached 70% of the total cells.
The fluorochrome DHE was used to assess superoxide 
radical production. The time course of the effect exerted by 
parthenolide on DHE signal is shown in Fig. 1B. We observed 
that the percentage of DHE-positive cells was very modest in 
the first 5 h of treatment, then progressively increased in the 
second phase of treatment (8-16 h), reaching a level near 75% 
at 16 h.
MitoSox Red was used to ascertain superoxide production at 
the mitochondrial level. As shown in Fig. 1C, the percentage of 
cells positive to MitoSox Red progressively increased from 8 to 
16 h of incubation. Results reported for MitoSox Red are similar 
to those ascertained for DHE signal. This finding suggests that 
O2•- assayed in the second phase of treatment with parthenolide 
was primarily produced at the mitochondrial level.
HPF is a fluorescent probe used to detect selectively hROS, 
such as hydroxyl radical and peroxynitrite, but not H2O2, NO 
and superoxide (18). As shown in Fig. 1D, positivity to HPF 
signal was particularly observed in the second phase of treat-
ment (8-16 h), reaching the maximum at 16 h when 75% of 
cells were positive to this signal. This result demonstrated that 
parthenolide in the second phase of treatment stimulated the 
production of hydroxyl radical and peroxynitrite.
Influence of apocynin and DPI on the effects exerted by 
parthenolide on ROS generation. Fig. 2 shows the influence 
exerted by apocynin and DPI, two effective inhibitors of NOX, 
Figure 1. Time course of cytofluorimetric analyses in MDA-MB-231 cells 
treated with parthenolide. Cells (105) were seeded in 6-well plates and treated 
with 25 µM parthenolide for different times. Analyses were performed at 
1, 3, 5, 8, 12 and 16 h, as reported in Materials and methods, using four 
different fluorescent probes: (A) dichlorofluorescein (DCF), (B) dihydro-
ethidium (DHE), (C) MitoSox Red and (D) hydroxyphenyl fluorescein 
(HPF). Analyses were performed by a Beckman Coulter cytometer using the 
EXPO32 software. All the results are expressed as percentage of fluorescent 
cells and are the mean ± SE of three independent experiments. *P<0.01 vs. 
untreated control.
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on the effects induced by parthenolide on ROS generation. It is 
of note that both inhibitors completely suppressed the effects 
on DCF signal found at 1 and 3 h of treatment with partheno-
lide. In addition, the inhibitors also markedly diminished the 
effect exerted on DCF signal at 8 h of treatment, whereas their 
effect was very modest, at 12 and 16 h of treatment (Fig. 2A).
Fig. 2B and C show that apocynin and DPI did not modify 
the effect induced by parthenolide on both DHE and MitoSox 
Red assays at 8 and 16 h. These results demonstrate that O2•- 
detected by these fluorochromes was not produced by NOX 
activity.
Time course of the parthenolide effect on manganese super-
oxide dismutase (MnSOD) and catalase levels. Fig. 3 shows the 
time course of the parthenolide effect on the level of MnSOD 
(SOD2) and catalase. The results demonstrated that in the first 
hours (0-4 h) of treatment, parthenolide did not modify the 
level of MnSOD and catalase, whereas after 4 h, the level of 
the two proteins progressively diminished and at 16 h it was 
reduced to ~40% of the control value. These results are in 
accordance with the previous observations of Sun et al (14).
Figure 2. The effects of NOX inhibitors on DCF, DHE and MitoSox Red 
signals. Cells were treated for the indicated times with 25 µM parthenolide 
without or with 100 µM apocynin or 10 µM DPI, DCF, DHE and MitoSox Red 
signals were estimated as described in Materials and methods. The results 
are the mean ± SE of three independent experiments. *P<0.01 vs. untreated 
control. **P<0.01 vs. cells treated with only parthenolide. NOX, NADPH 
oxidase; DCF, dichlorofluorescein; DHF, dihydroethidium; DPI, diphenyl-
eneiodonium.
Figure 3. The effect of parthenolide on the level of MnSOD and catalase. 
MDA-MB-231 cells (2x105 cells/well) were treated with 25 µM parthenolide 
for the indicated times. At the end, cell extracts were prepared as described in 
Materials and methods and submitted to western blot analysis using specific 
antibodies directed against MnSOD or catalase. The correct protein loading 
was ascertained by immunoblotting for β-actin. Densitometric evaluation is 
reported in the upper panel; the values are the means of three independent 
experiments ± SE. *P<0.01 vs. untreated control. MnSOD, manganese super-
oxide dismutase.
ONCOLOGY REPORTS  32:  167-172,  2014 171
Time course of the parthenolide effect on cell viability. Fig. 4 
shows the time course of the effect of parthenolide on cell 
viability. In particular, in the first 4 h of treatment, viability 
was reduced by only 4%, then the effect increased and at 8 h 
viability decreased to 65% of control. In the second phase of 
treatment, viability rapidly diminished and at 16 h was equal 
to 22% and at 24 h to only 8%.
To ascertain the effect of parthenolide on the production 
of necrotic cells, we employed PI, a cell-impermeable nuclear 
dye, which stains the nuclei of cells that have lost plasma 
membrane integrity and are considered necrotic. As shown in 
Fig. 4, the number of PI-positive cells increased slowly in the 
first phase of treatment (10% at 8 h). Between 8 and 20 h, the 
increment was more rapid, reaching a level of 60% at 16 h and 
80% at 24 h of treatment.
Discussion
In previous studies (13,15), we showed that parthenolide 
induces generation of ROS in MDA-MB-231 cells. The aim 
of the present study was to individuate the ROS produced 
under parthenolide treatment to specify the modalities of their 
production and the role exerted in the induction of cell death.
In order to clarify these aspects, at first we studied the 
effects exerted by 25 µM parthenolide during 24 h of treat-
ment on the viability of MDA-MB-231 cells. It was shown that 
in the first 4 h of treatment, the effect was very modest, while 
a marked reduction of the cell number was observed in the 
second phase of incubation (8-16 h).
Flow cytometric analysis of cellular ROS was performed 
in treated cells using fluorescent probes. DCFH-DA detects 
not only H2O2, but also hROS, such as hydroxyl radical and 
peroxynitrite, while DHE detects primarily O2•-.
It was observed that most of the cells were positive to 
DCF signal already at 1-3 h of treatment. Since this effect 
was suppressed by the addition of either apocynin or DPI, 
two effective inhibitors of NOX activity, we suggest that 
parthenolide, in line with previous findings (13,15), stimulated 
NOX activity, inducing production of O2•-, which was rapidly 
dismutated by SOD1 to produce H2O2. Also, at 8 h, apocynin 
and DPI exerted a marked inhibitory effect on DCF signal. 
Therefore, we conclude that in the first phase of treatment, the 
principal effect of parthenolide consists in the activation of 
NOX, followed by involvement of SOD1 with production of 
H2O2. This conclusion is also supported by the consideration 
that in this phase hROS were not produced, as indicated by the 
results obtained with HPF analysis (Fig. 1D).
DHE analysis showed that parthenolide stimulated this 
signal only in the second phase of treatment. O2•-, assayed by 
DHE analysis, was not produced by NOX activity since the 
signal was not diminished by the addition of either apocynin 
or DPI. Therefore, it seems likely that O2•- arises from mito-
chondrial activity, as suggested by positivity observed using 
MitoSox Red fluorochrome. It is possible that H2O2 can also 
be produced in this second phase of treatment. However, as 
DCF signal at 12 and 16 h was not inhibited by apocynin and 
DPI, we exclude that in this phase generation of H2O2 can be a 
consequence of activation of NOX, unlike the effect observed 
in the first hours of treatment.
Our results clearly demonstrate that parthenolide induced, 
in this second phase, production of hROS (hydroxyl radical 
and peroxynitrite), as suggested by the results of HPF analysis. 
In this phase, as previously ascertained by us (13), parthenolide 
caused mitochondrial dysfunction with a marked fall in ∆ψm. 
Mitochondrial damage could be responsible for the production 
of either O2•- and hROS. In particular, peroxynitrite could be 
produced by a specific reaction between O2•- and NO (6) and 
could contribute to positivity found with both DCF and HPF 
signals in the second phase of incubation. The marked decre-
ment in the level of both MnSOD and catalase, found in this 
phase of treatment, can contribute to determine the rise of O2•- 
and hROS. Finally, it is interesting to note that peroxynitrite 
and hydroxyl radical can in turn induce mitochondrial damage 
and further production of ROS (6).
A comparison between the time course of the parthenolide 
effect on cell viability and the production of ROS leads to the 
following conclusions: i) in a first phase of treatment (0-8 h), 
and in particular in the first 4 h, the effect on cell viability was 
very modest, while most of the cells were positive to DCF signal 
owing to the production of H2O2; and ii) in the second phase 
(8-16 h), a strong effect on cell viability was observed, just when 
mitochondrial damage leads to the production of O2•- and hROS. 
These results suggest that O2•- and hROS may play a central role 
in the induction of cell death by parthenolide treatment.
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Figure 4. The effect of parthenolide on cell viability and cell necrosis. 
MDA-MB-231 cells (8x103/well) were treated for various times with 25 µM 
parthenolide. (●) Cytotoxic effects exerted by parthenolide on cell viability. 
Cell viability was assessed by MTT assay, as reported in Materials and 
methods. (▲) Cell necrosis determined by propidium iodide (PI) staining. 
After treatment, the cells were incubated for 15 min with PI (2.0 µg/ml 
medium; red fluorescence) and the percentage of PI-positive cells was ascer-
tained as described in Materials and methods. The values are the means of 
three independent experiments ± SE. *P<0.01 vs. untreated control.
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